Heart rate and arterial pressure variability in the experimental renovascular hypertension model in rats

Autonomic Neuroscience: Basic and Clinical

Volumn 139, Issue 1-2, 2008, Pages 38-45

  Souza, Hugo C D ^a   Martins Pinge, Marli C ^b   Dias da Silva, Valdo J ^c   Borghi Silva, Audrey ^d   Gastaldi, Ada C ^a   Blanco, João Henrique D ^a   Tezini, Geisa C S V ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF LONDRINA   (Brazil)

^c FEDERAL UNIVERSITY OF TRIÂNGULO MINEIRO   (Brazil)

^d FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

Author keywords

Cardiovascular autonomic control; Renovascular hypertension; Spectral analysis

Indexed keywords

METHYLATROPINE; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BLOOD PRESSURE; BLOOD PRESSURE VARIABILITY; CONTROLLED STUDY; HEART FUNCTION; HEART RATE VARIABILITY; HEART RHYTHM; MALE; NERVE BLOCK; NONHUMAN; OSCILLATION; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; RENOVASCULAR HYPERTENSION; SPECTROSCOPY; SYMPATHETIC TONE; TACHYCARDIA; VAGUS NERVE;

ANIMALS; BAROREFLEX; BLOOD PRESSURE; DISEASE MODELS, ANIMAL; HEART RATE; HYPERTENSION, RENOVASCULAR; MALE; RATS; RATS, WISTAR; SPECTRUM ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 41149136032     PISSN: 15660702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autneu.2008.01.001     Document Type: Article

References (41)

1. Bergamaschi C., Campos R.R., Schor N., and Lopes O.U. Role of the rostral ventrolateral medulla in maintenance of blood pressure in rats with Goldblatt hypertension. Hypertension 26 (1995) 1117-1120
2. Carvalho T.H., Bergamaschi C.T., Lopes O.U., and Campos R.R. Role of endogenous angiotensin II on glutamatergic actions in the rostral ventrolateral medulla in Goldblatt hypertensive rats. Hypertension 42 (2003) 707-712
3. Cerutti C., Gustin M.P., Paultre C.Z., Lo M., Julien C., Vincent M., and Sassard J. Autonomic nervous system and cardiovascular variability in rats: a spectral analysis approach. Am. J. Physiol., Heart Circ. Physiol. 261 (1991) H1292-H1299
4. De Boer R.W., Karemaker J.M., and Strackee J. Hemodynamic fluctuations and baroreflex sensitivity in humans: a beat-to-beat model. Am. J. Physiol. 253 (1987) H680-H689
5. Dibona G.F., and Kopp U.C. Neural control of renal function. Physiol. Rev. 77 (1997) 75-197
6. Farah V.M.A., Moreira E.D., Ushizima M., Cestari I.A., Irigoyen M.C., and Krieger E.M. Acute AT1 receptor blockade does not improve the depressed baroreflex in rats with chronic renal hypertension. Braz. J. Med. Biol. Res. 33 (2000) 1491-1496
7. Goldblatt H., Lynch J., Hanzal R.F., and Summerville W.W. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 59 (1934) 347-378
8. Hansen K.J., Edwards M.S., Craven T.E., Cherr G.S., Jackson S.A., Appel R.G., Burke G.L., and Dean R.H. Prevalence of renovascular disease in the elderly: a population-based study. J. Vasc. Surg. 36 3 (2002) 443-451
9. Hausberg M., Kosch M., Harmelink P., Barenbrock M., Hohage H., Kisters K., Dietl K.H., and Rahn K.H. Sympathetic nerve activity in end-stage renal disease. Circulation 106 (2002) 1974-1979
10. Head G.A., and Mccarty R. Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats. J. Auton. Nerv. Syst. 21 (1987) 203-213
11. Head G.A., and Burke S.L. Sympathetic responses to stress and rilmenidine in 2K1C rabbits. Evidence of enhanced nonvascular effector mechanism. Hypertension 43 (2004) 636-642
12. Houle M.S., and Billman G.E. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity. Am. J. Physiol. 276 1 Pt 2 (1999) H215-H223
13. Irigoyen M.C., and Krieger E.M. Baroreflex control of sympathetic activity in experimental hypertension. Braz. J. Med. Biol. Res. 31 9 (1998) 1213-1220
14. Japundzic N., Grichois M., Zitoun P., Laude D., and Elghozi J. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J. Auton. Nerv. Syst. 30 (1990) 91-100
15. Johansson M., Elam M., Rundqvist B., Eisenhofer G., Herlitz H., and Friberg P. Increased sympathetic nerve activity in renovascular hypertension. Circulation 99 (1999) 2537-2542
16. Katahira K., Mikami A., Otsuka A., Moriguchi A., Kohara K., Higaschimori K., Okuda M., Nagano M., Morishita R., and Ogihara T. Differential control of vascular tone and heart rate by different amino acid neurotransmitters in the rostral ventrolateral medulla of the rat. Clin. Exp. Pharmacol. Physiol. 21 (1994) 545-556
17. Klein I.H.H.T., Ligtenberg G., Neumann J., Oey P.L., Koomans H.A., and Blankestijn P.J. Sympathetic nerve activity is inappropriately increased in chronic renal disease. J. Am. Soc. Nephrol. 14 (2003) 3239-3244
18. Kubo T., Fukumori R., Kobayashi M., and Yamaguchi H. Enhanced cholinergic activity in the medulla oblongata of DOCA-salt hypertensive and renal hypertension rats. Hypertens. Res. 19 (1996) 213-219
19. Levy D., and Kannel W.B. Cardiovascular risks: new insights from Framingham. Am. Heart J. 116 1 Pt 2 (1988) 266-272
20. Machado B.H., and Brody M.J. Contribution of neurogenic mechanisms to control of intrinsic heart rate. Am. J. Physiol. 256 1 Pt 2 (1989) R231-R235
21. Machado B.H., and Salgado H.C. Intrinsic heart rate after infusion of angiotensin II in rats with sino-aortic deafferentation. Braz. J. Med. Biol. Res. 23 (1990) 337-341
22. Machado B.H., Krieger E.M., and Salgado H.C. Changes of the intrinsic heart rate during the onset of renal hypertension. J. Hypertens. 5 (1987) 755-759
23. Malliani A., Pagani M., Lombardi F., and Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84 (1991) 482-492
24. Mancia G., Frattola A., Parati G., Santucciu C., and Ulian L. Blood pressure variability and organ damage. J. Cardiovasc. Pharmacol. 24 Suppl. A (1994) S6-S11
25. Marquardt P.W. An algorithm for least-squares estimation of nonlinear parameters. J. Soc. Ind. Appl. Math. 26 (1963) 431-441
26. Menani J.V., Machado B.H., Krieger E.M., and Salgado H.C. Tachycardia during the onset of one-kidney, one-clip renal hypertension: role of the renin-angiotensin system and AV3V tissue. Brain Res. 19;446 2 (1988) 295-302
27. Miyajima E., Yamada Y., Yoshida Y., Matsukawa T., Shionoiri H., Tochikubo O., and Ishii M. Muscle sympathetic nerve activity in renovascular hypertension and primary aldosteronism. Hypertension 17 (1991) 1057-1062
28. Mussalo H., Vanninen E., Ikäheimo R., Laitinen T., Laakso M., Länsimies E., and Hartikainen J. Heart rate variability and its determinants in patients with severe or mild essential hypertension. Clin. Physiol. 21 5 (2001) 594-604
29. Mussalo H., Vanninen E., Aheimo R.I.K., and Laitinen T. Short-term blood pressure variability in renovascular hypertension and in severe and mild essential hypertension. Clin. Sci. 105 (2003) 609-614
30. Nafz B., Seelinger E., and Persson P.B. Nitric oxide and the role of blood pressure variability to the kidney. Acta Physiol. Scand. 173 (2001) 45-49
31. Neumann J., Ligtenberg G., Oey L., Koomans H.A., and Blankestijn P.J. Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure. J. Am. Soc. Nephrol. 15 11 (2004) 2902-2907
32. Nobre F., Silva C.A., Coelho E.B., Salgado H.C., and Fazan R. Antihypertensive agents have different ability to modulate arterial pressure and heart rate variability in 2K1C rats. Am. J. Hypertens. 19 10 (2006) 1079-1083
33. Oliveira P.F., Dias da Silva V.J., Salgado M.C., Fazan R., Aguiar C.A., and Salgado H.C. Acute effect of amiodarone on cardiovascular reflexes of normotensive and renal hypertensive rats. Braz. J. Med. Biol. Res. 38 6 (2005) 67-76
34. Rubini R., Porta A., Baselli G., Cerutti S., and Paro M. Power spectrum analysis of cardiovascular variability monitored by telemetry in conscious unrestrained rats. J. Auton. Nerv. Syst. 45 (1993) 181-190
35. Schaffenburg C.A. Device to control constriction of main renal artery for production of hypertension in small animals. Proc. Soc. Exp. Biol. Med. 101 (1959) 676-677
36. Skyschally A., Breuer H.W., and Heusch G. The analysis of heart rate variability does not provide a reliable measurement of cardiac sympathetic activity. Clin. Sci. 91 (1996) 102-104 (Lond) Suppl
37. Sytkowski P.A., D'Agostino R.B., Belanger A.J., and Kannel W.B. Secular trends in long-term sustained hypertension, long-term treatment, and cardiovascular mortality. The Framingham Heart Study 1950 to 1990. Circulation 15:93 4 (1996) 697-703
38. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation 93 (1996) 1043-1065
39. Wang D.S., Xie H.H., Shen F.M., Cai G.J., and Su D.F. Blood pressure variability, cardiac baroreflex sensitivity and organ damage in experimentally hypertensive rats. Clin. Exp. Pharmacol. Physiol. 32 7 (2005) 545-552
40. Yamamoto Y., Hughson R.L., and Peterson J.C. Autonomic control of heart rate during exercise studied by heart rate variability spectral analysis. J. Appl. Physiol. 71 3 (1991) 1136-1142
41. Zanchetti A., and Mancia G. Blood pressure and organ damage. J. Cardiovasc. Pharmacol. 10 Suppl 6 (1987) S111-S118